NCT00482781

Brief Summary

The purpose of this study is to examine the relationship between receipt of DTaP and the occurrence of prolonged episodes of apnea and bradycardia in preterm infants, while employing a random control study design and an objective assessment of cardiorespiratory events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
191

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2000

Longer than P75 for not_applicable

Geographic Reach
1 country

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2000

Completed
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2004

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

June 1, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 5, 2007

Completed
Last Updated

June 5, 2007

Status Verified

June 1, 2007

First QC Date

June 1, 2007

Last Update Submit

June 4, 2007

Conditions

Keywords

ApneaBradycardiaPreterm InfantImmunizationDTaP

Outcome Measures

Primary Outcomes (1)

  • Bedside recording of apnea and bradycardia with events verified by 2 independent scorers who were blinded to the study phase and immunization status of the subject.

    Six days (Three 48-hour periods).

Interventions

InfanrixBIOLOGICAL
PediatrixBIOLOGICAL

Eligibility Criteria

Age56 Days - 60 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Born at a gestational age \< 37 weeks.
  • Still in the hospital at time of study.
  • Between 56 - 60 days chronological age.

You may not qualify if:

  • Had active infections, were critically ill, or had unstable vital signs.
  • Requiring assisted ventilation or tracheostomy during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

Wellstar Cobb Hospital

Austell, Georgia, 30106, United States

Location

Kennestone Hospital

Marietta, Georgia, 30060, United States

Location

St. Peters Univ. Hospital

Belle Mead, New Jersey, 08502, United States

Location

Brooklyn Hospital

Brooklyn, New York, 11201, United States

Location

St. Joseph's Hospital Health Ctr.

Syracuse, New York, 13203, United States

Location

Toledo Children's Hospital

Toledo, Ohio, 43606, United States

Location

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States

Location

Western Pennsylvania Hospital

Pittsburgh, Pennsylvania, 15224, United States

Location

The Children's Home of Pittsburgh

Pittsburgh, Pennsylvania, 15232, United States

Location

Children's Hospital

Greenville, South Carolina, 29605, United States

Location

Related Publications (1)

  • Carbone T, McEntire B, Kissin D, Kelly D, Steinschneider A, Violaris K, Karamchandani N. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study. Pediatrics. 2008 May;121(5):e1085-90. doi: 10.1542/peds.2007-2059.

MeSH Terms

Conditions

ApneaBradycardiaPremature Birth

Interventions

Diphtheria-Tetanus-acellular Pertussis Vaccines

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsArrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Pertussis VaccineBacterial VaccinesVaccinesBiological ProductsComplex MixturesDiphtheria ToxoidToxoidsTetanus ToxoidVaccines, CombinedVaccines, AcellularVaccines, Subunit

Study Officials

  • Tracy Carbone, MD

    Valley Hospital, Ridgewood, NJ

    PRINCIPAL INVESTIGATOR
  • Betty McEntire, PhD

    American SIDS Institute

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 1, 2007

First Posted

June 5, 2007

Study Start

September 1, 2000

Study Completion

September 1, 2004

Last Updated

June 5, 2007

Record last verified: 2007-06

Locations